Anoxic ATP depletion in neonatal mice brainstem is prevented by creatine supplementation
B Wilkena, J M Ramirezd, I Probstc, D W Richterb, F Hanefelda
a Klinik für
Pädiatrie und Neuropädiatrie, Universität Göttingen, 37075 Göttingen, Germany, b Institut für Neurophysiologie und
Sinnesphysiologie, Universität Göttingen, c Institut für Biochemie I, Universität
Göttingen, d Department
of Organismal Biology and Anatomy, University of Chicago, Chicago,
Illinois 60637, USA
Correspondence to: Professor F Hanefeld, University of Göttingen, Pediatric and Pediatric Neurology, Robert-Koch-Str. 40, 37075 Göttingen, Germany
Accepted 22
October 1999
BACKGROUND
Sufficient
ATP concentrations maintain physiological processes and protect tissue
from hypoxic damage. With decreasing oxygen concentration, ATP
synthesis relies increasingly on the presence of phosphocreatine.
AIM
The effect of
exogenously applied creatine on phosphocreatine and ATP concentrations
was studied under control and anoxic conditions.
METHODS
Pregnant mice
were fed orally with creatine monohydrate (2 g/kg body weight/day).
Brainstem slices from these mice pups were compared with those from
pups of non-creatine supplemented pregnant mice. Measurements were
performed under normoxic and anoxic conditions. In addition, brainstem
slices from non-creatine treated mice pups were incubated for 3 hours
in control artificial cerebrospinal fluid (CSF) (n = 10) or in
artificial CSF containing 200 µM creatine (n = 10). ATP and
phosphocreatine contents were determined enzymatically in single
brainstem slices.
RESULTS
ATP
concentrations were in the same range in all preparations. However,
there was a significant increase of phosphocreatine in the brainstems
from pups of creatine fed mice when compared with the brainstems of
pups from non-creatine treated mice or in non-incubated brainstems of
control animals. After 30 minutes anoxia, ATP as well as
phosphocreatine concentrations remained significantly higher in
creatine pretreated slices compared with controls.
CONCLUSION
The data
indicate that exogenous application of creatine is effective in neuroprotection.
Keywords: ATP; creatine; phosphocreatine; neuroprotection
© 2000 by Archives of Disease in Childhood
This article has been cited by other articles:
-
Gerich, F. J., Hepp, S., Probst, I., Muller, M.
(2006). Mitochondrial Inhibition Prior to Oxygen-Withdrawal Facilitates the Occurrence of Hypoxia-Induced Spreading Depression in Rat Hippocampal Slices. J. Neurophysiol.
96: 492-504
[Abstract] [Full Text] -
Bohnhorst, B., Geuting, T., Peter, C. S., Dordelmann, M., Wilken, B., Poets, C. F.
(2004). Randomized, Controlled Trial of Oral Creatine Supplementation (Not Effective) for Apnea of Prematurity. Pediatrics
113: e303-e307
[Abstract] [Full Text] -
Persky, A. M., Brazeau, G. A.
(2001). Clinical Pharmacology of the Dietary Supplement Creatine Monohydrate. Pharmacol. Rev.
0: 1-
[Abstract] [Full Text] -
Persky, A. M., Brazeau, G. A.
(2001). Clinical Pharmacology of the Dietary Supplement Creatine Monohydrate. Pharmacol. Rev.
53: 161-176
[Abstract] [Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



